Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SNX281 |
Trade Name | |
Synonyms | SNX-281|SNX 281 |
Drug Descriptions |
SNX281 acts as an agonist to stimulator of interferon genes (STING, TMEM173), which activates the immune system by stimulating cells in the tumor microenvironment, potentially resulting in a cytotoxic T-lymphocyte response against tumor cells (NCI Drug dictionary). |
DrugClasses | STING1 Agonist 19 |
CAS Registry Number | NA |
NCIT ID | C179271 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + SNX281 | Pembrolizumab SNX281 | 0 | 1 |
SNX281 | SNX281 | 0 | 1 |